James P Mackin $AORT SEC Form 4 Insider Trading

James P Mackin has filed a total of 29 insider trades in $AORT since 2021. Their most recent trade was a sale of 14,911 shares, made on Mar 02, 2026. Their largest trade was a sale of 70,700 shares, made on Mar 06, 2025. We estimate that they now own 863,125 shares of $AORT, worth an estimated $38.5 million.

Insider Trading at $AORT

There have been a total of 209 insider trades reported at $AORT since 2021, with 0 shares purchased and 1.2 million shares sold. The most active insider traders in $AORT stock have been Jean F Holloway, Marshall S. Stanton, and James P Mackin. The most recent trade was a sale of 641 shares reported by Amy Horton (VP, Chief Accounting Officer), made on Mar 02, 2026.

$AORT Executives and Stock Owners with Insider Trades

• Jean F Holloway, SVP, General Counsel

• Marshall S. Stanton, SVP, Clinical & MD Affair

• James P Mackin, President & CEO

• Amy Horton, VP, Chief Accounting Officer

• John E Davis, Chief Commercial Officer

• Matthew A Getz, VP, Human Resources

• Andrew M Green, VP Regulatory

• Dennis B Maier, SVP, Operations

• Rochelle L. Maney, VP, Quality

• David Ashley Lee, Executive VP, COO & CFO

• John E Davis, Senior VP, Global Sales

• Florian Tyrs, VP, Global Operations

• Lance A Berry, EVP, COO, CFO & Treasurer

• Lance A Berry, Executive VP, CFO

*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.